000			01870 a2200505 4500
005			20250513090148.0
264		0	_c19960605
008			199606s 0 0 eng d
022			_a0009-9236
024	7		_a10.1016/S0009-9236(96)90115-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aIlli, A
245	0	0	_aSimultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers. _h[electronic resource]
260			_bClinical pharmacology and therapeutics _cApr 1996
300			_a450-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAnalysis of Variance
650	0	4	_aAntidepressive Agents _xpharmacology
650	0	4	_aAntiparkinson Agents _xpharmacology
650	0	4	_aBenzamides _xadministration & dosage
650	0	4	_aCatechol O-Methyltransferase Inhibitors
650	0	4	_aCatecholamines _xblood
650	0	4	_aCatechols _xadministration & dosage
650	0	4	_aCross-Over Studies
650	0	4	_aDepressive Disorder _xdrug therapy
650	0	4	_aDouble-Blind Method
650	0	4	_aExercise
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMoclobemide
650	0	4	_aMonoamine Oxidase Inhibitors _xadministration & dosage
650	0	4	_aNitriles
650	0	4	_aParkinson Disease _xdrug therapy
650	0	4	_aReference Values
650	0	4	_aRest
700	1		_aSundberg, S
700	1		_aOjala-Karlsson, P
700	1		_aScheinin, M
700	1		_aGordin, A
773	0		_tClinical pharmacology and therapeutics _gvol. 59 _gno. 4 _gp. 450-7
856	4	0	_uhttps://doi.org/10.1016/S0009-9236(96)90115-0 _zAvailable from publisher's website
999			_c8611437 _d8611437